TBIO Financials
Telesis Bio Inc - Financial statements & key metrics
Stock Price
$0.05
Market Cap
$97,671
EPS
$-30.42
Income Statement Highlights
Most Recent Quarter: 2023-12-31
Revenue
$27.51M
Gross Profit
$16.95M
Operating Income
$-46.54M
Net Income
$-47.72M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$70.41M
Total Liabilities
$40.87M
Shareholders Equity
$29.54M
Cash & Equivalents
$1.57M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-34.67M
CapEx
$1.98M
Free Cash Flow
$-36.65M
Profitability Metrics
Gross Margin
46.9%
Operating Margin
-3.3%
Net Margin
-2.7%
ROE
-1.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is TBIO revenue?
TBIO's most recent quarterly revenue was $27.51M. Annual revenue can be calculated by summing the four most recent quarters.
Is TBIO profitable?
TBIO reported a loss of $47.72M in the most recent quarter. The net profit margin is -2.7%.
What is TBIO market cap?
TBIO has a market capitalization of $97,671, making it a small-cap stock.
Does TBIO have debt?
View TBIO's balance sheet for debt information.
What is TBIO cash flow?
TBIO's most recent quarterly free cash flow was $-36.65M.